Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

177 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Metabolic syndrome and cardiovascular risk.
Alshehri AM. Alshehri AM. J Family Community Med. 2010 May;17(2):73-8. doi: 10.4103/1319-1683.71987. J Family Community Med. 2010. PMID: 21359028 Free PMC article.
Prevalence of CYP2C19*2 carriers in Saudi ischemic stroke patients and the suitability of using genotyping to guide antiplatelet therapy in a university hospital setup.
Al-Rubaish AM, Al-Muhanna FA, Alshehri AM, Alsulaiman AA, Alabdulali MM, Alkhamis F, Alamri AS, Alali RA, Akhtar MS, Cyrus C, Claassens DMF, Asselbergs FW, Al-Ali AK. Al-Rubaish AM, et al. Among authors: alshehri am. Drug Metab Pers Ther. 2021 Jul 8. doi: 10.1515/dmdi-2021-0104. Online ahead of print. Drug Metab Pers Ther. 2021. PMID: 34237806
Prevalence of CYP2C19*2 carriers in Saudi ischemic stroke patients and the suitability of using genotyping to guide antiplatelet therapy in a university hospital setup.
Al-Rubaish AM, Al-Muhanna FA, Alshehri AM, Alsulaiman AA, Alabdulali MM, Alkhamis F, Alamri AS, Alali RA, Akhtar MS, Cyrus C, Claassens DMF, Asselbergs FW, Al-Ali AK. Al-Rubaish AM, et al. Among authors: alshehri am. Drug Metab Pers Ther. 2021 Jul 8;37(1):35-40. doi: 10.1515/dmpt-2021-0104. Drug Metab Pers Ther. 2021. PMID: 35385889
Bedside testing of CYP2C19 gene for treatment of patients with PCI with antiplatelet therapy.
Al-Rubaish AM, Al-Muhanna FA, Alshehri AM, Al-Mansori MA, Alali RA, Khalil RM, Al Faraidy KA, Cyrus C, Sulieman MM, Vatte C, Claassens DMF, Ten Berg JM, Asselbergs FW, Al-Ali AK. Al-Rubaish AM, et al. Among authors: alshehri am. BMC Cardiovasc Disord. 2020 Jun 3;20(1):268. doi: 10.1186/s12872-020-01558-2. BMC Cardiovasc Disord. 2020. PMID: 32493215 Free PMC article.
Bedside testing of CYP2C19 vs. conventional clopidogrel treatment to guide antiplatelet therapy in ST-segment elevation myocardial infarction patients.
Al-Rubaish AM, Al-Muhanna FA, Alshehri AM, Al-Mansori MA, Alali RA, Khalil RM, Al-Faraidy KA, Cyrus C, Sulieman MM, Vatte C, Loza BL, Claassens DMF, Asselbergs FW, Al-Ali AK. Al-Rubaish AM, et al. Among authors: alshehri am. Int J Cardiol. 2021 Nov 15;343:15-20. doi: 10.1016/j.ijcard.2021.08.051. Epub 2021 Sep 11. Int J Cardiol. 2021. PMID: 34506827 Free article. Clinical Trial.
Reply to the Letter to the Editor: "It is urgent to evaluate the efficacy and safety of genotype guided antiplatelet therapy in patients after percutaneous coronary intervention in East Asian".
Al-Rubaish AM, Al-Muhanna FA, Alshehri AM, Al-Mansori MA, Alali RA, Khalil RM, Al-Faraidy KA, Cyrus C, Sulieman MM, Vatte C, Loza BL, Claassens DMF, Asselbergs FW, Al-Ali AK. Al-Rubaish AM, et al. Among authors: alshehri am. Int J Cardiol. 2022 Feb 1;348:57. doi: 10.1016/j.ijcard.2021.11.069. Epub 2021 Dec 9. Int J Cardiol. 2022. PMID: 34896105 No abstract available.
177 results